BVF INC/IL
CIK 1056807 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $3.9B
- Posisi
- 44
- Per tanggal
- 30 Juni 2026
#950 dari 9.443 berdasarkan nilai 13F · top 10.1%
Nilai portofolio QoQ: +24.6% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 65,59%
- Bobot 25 kepemilikan teratas
- 92,49%
- Posisi di atas 1%
- 24
- Jumlah posisi efektif
- 16,0
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 10,24% Perkiraan pembelian $360.794.624 · penjualan $421.105.332
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 56,4% masih dipegang
- Posisi baru
- 7
- Meningkat
- 6
- Menurun
- 8
- Tertutup
- 4
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +50.7% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 98,6% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
99,6%
Lainnya/Tidak terpetakan
0,4%
Portofolio lengkap 44 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. - Common Stock | $555.315.165 | 14,20% | 2.965.160 | $277.493.115 | Naik ×1 | ||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $444.008.203 | 11,35% | 3.872.052 | $-14.312.513 | Turun ×1 | ||
| XOMA XOMA Royalty Corporation - Common Stock | $322.715.378 | 8,25% | 7.593.303 | $241.457.573 | Naik ×1 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $311.544.999 | 7,97% | 16.001.284 | $13.281.065 | |||
| GHRS GH Research PLC - Ordinary Shares | $232.516.247 | 5,95% | 8.650.158 | $110.895.026 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $180.697.390 | 4,62% | 3.366.823 | $13.956.334 | Turun ×2 | ||
| NKTR Nektar Therapeutics - Common Stock | $166.920.946 | 4,27% | 2.391.075 | $-17.241.914 | Turun ×1 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $123.629.081 | 3,16% | 1.056.027 | $-22.767.999 | Turun ×1 | ||
| XNCR Xencor, Inc. - Common Stock | $114.852.892 | 2,94% | 7.133.720 | $28.820.229 | |||
| ALKS Alkermes plc - Ordinary Shares | $112.895.716 | 2,89% | 2.154.704 | $42.175.716 | Naik ×1 | ||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $107.953.441 | 2,76% | 4.460.886 | $34.571.866 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $104.719.937 | 2,68% | 5.750.683 | $23.002.732 | |||
| PVLA Palvella Therapeutics, Inc. - Common Stock | $102.815.615 | 2,63% | 672.789 | $-16.971.664 | Turun ×1 | ||
| ZYME Zymeworks Inc. - Common Stock | $95.388.572 | 2,44% | 3.649.142 | $1.885.656 | Turun ×2 | ||
| KURA Kura Oncology, Inc. - Common Stock | $92.650.086 | 2,37% | 8.445.769 | $23.985.984 | |||
| IRON Disc Medicine, Inc. - Common Stock | $84.375.182 | 2,16% | 1.153.612 | $3.023.553 | Turun ×1 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $83.356.065 | 2,13% | 2.547.557 | $407.609 | |||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $66.251.621 | 1,69% | 5.295.893 | $-12.710.144 | |||
| ANNX Annexon, Inc. - common stock | $49.666.568 | 1,27% | 8.698.173 | $1.478.690 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $49.477.734 | 1,27% | 2.748.763 | $-1.017.042 | |||
| ACIU AC Immune SA - Common Stock | $47.177.398 | 1,21% | 19.822.436 | $-7.334.301 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $47.149.700 | 1,21% | 1.476.196 | $-28.538.607 | Turun ×4 | ||
| STRO Sutro Biopharma, Inc. - Common Stock | $41.559.362 | 1,06% | 1.251.788 | $10.377.323 | |||
| IMCR Immunocore Holdings plc - American Depositary Shares | $41.099.200 | 1,05% | 1.294.463 | $2.071.141 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $38.356.072 | 0,98% | 2.075.545 | $13.977.696 | Naik ×4 | ||
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $38.294.544 | 0,98% | 2.879.289 | $11.488.363 | |||
| QTTB Q32 Bio Inc. - Common Stock | $29.939.000 | 0,77% | 2.350.000 | Naik ×1 | |||
| AVR Anteris Technologies Global Corp. - Common Stock | $29.550.000 | 0,76% | 3.000.000 | $12.900.000 | |||
| FHTX Foghorn Therapeutics Inc. - Common Stock | $28.508.960 | 0,73% | 5.842.000 | $584.200 | |||
| ABSI Absci Corporation - Common Stock | $27.371.802 | 0,70% | 2.361.674 | Naik ×1 | |||
| ELDN Eledon Pharmaceuticals, Inc. - Common Stock | $24.795.531 | 0,63% | 6.293.282 | $5.412.222 | |||
| IVVD Invivyd, Inc. - Common Stock | $24.571.146 | 0,63% | 28.165.000 | $-811.354 | Naik ×1 | ||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $19.325.000 | 0,49% | 2.500.000 | Naik ×1 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $14.755.148 | 0,38% | 3.235.778 | $6.562.204 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 4525EP200) | $11.762.584 | 0,30% | 765.295 | Naik ×1 | |||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $10.431.575 | 0,27% | 2.233.742 | $1.206.221 | |||
| IMA ImageneBio, Inc. - Common Stock | $6.549.012 | 0,17% | 1.110.002 | $999.002 | |||
| TCRX TScan Therapeutics, Inc. - Common Stock | $5.453.561 | 0,14% | 5.564.290 | $-166.372 | |||
| Penerbit tidak dikenal (CUSIP: G75226103) | $5.350.000 | 0,14% | 500.000 | Naik ×1 | |||
| MOLN Molecular Partners AG - American Depositary Shares | $5.145.078 | 0,13% | 1.353.968 | $-216.635 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $4.940.438 | 0,13% | 339.549 | $-488.951 | |||
| ENTX Entera Bio Ltd. - Ordinary Shares | $4.292.250 | 0,11% | 2.425.000 | Naik ×1 | |||
| IVA Inventiva S.A. - American Depository Shares | $2.593.231 | 0,07% | 686.040 | $-1.214.291 | |||
| Penerbit tidak dikenal (CUSIP: 29286X119) | $274.072 | 0,01% | 945.402 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
| Sekuritas | Nilai | % dari portofolio | Rentetan |
|---|---|---|---|
| AVTX | $38.356.072 | 0,98% | naik ×4 |
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| QTTB | $29.939.000 | 2.350.000 | 0,77% |
| ABSI | $27.371.802 | 2.361.674 | 0,70% |
| SGMT | $19.325.000 | 2.500.000 | 0,49% |
| Penerbit tidak dikenal (CUSIP: 4525EP200) | $11.762.584 | 765.295 | 0,30% |
| Penerbit tidak dikenal (CUSIP: G75226103) | $5.350.000 | 500.000 | 0,14% |
| ENTX | $4.292.250 | 2.425.000 | 0,11% |
| Penerbit tidak dikenal (CUSIP: 29286X119) | $274.072 | 945.402 | 0,01% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Beli lebih banyak | +108K | +$277.5M |
| XOMA | Beli lebih banyak | +5.0M | +$241.5M |
| GHRS | Hanya pergerakan harga | +0 | +$110.9M |
| ALKS | Beli lebih banyak | +155K | +$42.2M |
| GLUE | Hanya pergerakan harga | +0 | +$34.6M |
| XNCR | Hanya pergerakan harga | +0 | +$28.8M |
| TYRA | Dipangkas | -500K | -$28.5M |
| KURA | Hanya pergerakan harga | +0 | +$24.0M |
| CGEM | Hanya pergerakan harga | +0 | +$23.0M |
| MIRM | Dipangkas | -529K | -$22.8M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| PTGX | 31 Des. 2025 | 2.560.916 | $170.121.650 | 80,5% |
| CDTX | 31 Des. 2025 | 1.414.165 | $135.420.440 | Tidak lagi dilacak |
| IONS | 30 Sep. 2025 | 1.913.385 | $75.597.841 | -7,8% |
| ABVX | 31 Maret 2026 | 508.031 | $68.510.521 | 7,8% |
| CMPX | 30 Juni 2026 | 7.764.842 | $41.076.014 | 13,5% |
| GLPG | 30 Juni 2025 | 1.454.422 | $36.535.081 | Tidak lagi dilacak |
| AGIO | 31 Maret 2025 | 1.073.755 | $35.283.589 | 20,9% |
| ETNB | 31 Maret 2025 | 4.333.885 | $33.890.981 | Tidak lagi dilacak |
| CELC | 31 Des. 2025 | 658.421 | $32.525.997 | -4,9% |
| SEPN | 30 Juni 2026 | 1.353.249 | $32.518.573 | 31,4% |
| VERV | 30 Juni 2025 | 6.904.050 | $31.551.509 | Tidak lagi dilacak |
| RPTX | 31 Maret 2026 | 10.333.600 | $26.867.360 | Tidak lagi dilacak |
| ITOS | 30 Juni 2025 | 3.075.000 | $18.357.750 | Tidak lagi dilacak |
| VSTM | 30 Sep. 2025 | 3.404.425 | $14.128.364 | -14,9% |
| ENGN | 31 Maret 2025 | 2.106.037 | $14.005.146 | -60,9% |
| PEPG | 31 Maret 2026 | 1.915.000 | $12.466.650 | 63,8% |
| RAPT | 30 Sep. 2025 | 1.154.692 | $9.237.536 | Tidak lagi dilacak |
| IMUX | 30 Juni 2026 | 7.652.972 | $8.494.799 | 10,8% |
| AXSM | 31 Maret 2026 | 45.757 | $8.357.058 | 30,4% |
| THRD | 30 Juni 2025 | 2.372.933 | $8.234.078 | Tidak lagi dilacak |
| VIGL | 30 Juni 2025 | 4.013.633 | $7.144.267 | Tidak lagi dilacak |
| IKNA | 30 Sep. 2025 | 4.006.564 | $5.368.796 | Tidak lagi dilacak |
| ALLK | 30 Juni 2025 | 16.552.417 | $3.767.330 | Tidak lagi dilacak |
| CTMX | 30 Juni 2025 | 5.228.461 | $3.324.256 | 55,1% |
| ENGNW | 30 Juni 2026 | 945.402 | $2.486.407 | -89,0% |
| EPIX | 31 Des. 2025 | 11.668.473 | $2.228.678 | Tidak lagi dilacak |
| GLYC | 30 Juni 2025 | 9.544.262 | $2.004.295 | Tidak lagi dilacak |
| SABS | 31 Des. 2025 | 932.697 | $1.874.721 | 2,9% |
| ELEV | 31 Maret 2025 | 2.966.836 | $1.669.142 | Tidak lagi dilacak |
| OVID | 30 Sep. 2025 | 3.853.818 | $1.271.375 | 122,7% |
| NAMS | 30 Juni 2025 | 59.065 | $1.209.061 | 53,6% |
| FBRX | 31 Des. 2025 | 65.350 | $980.250 | 182,1% |
| NLSP | 31 Des. 2025 | 143.676 | $262.927 | Tidak lagi dilacak |